<*dv_1*> AGS was founded by current and former Yale scientists, Professors Frank Ruddle (Yale University), Adrian Hayday (University of London) and Dr. Cooduvalli Shashikant (Penn State University).  Yale University is one of its founding partners and technology licensors.  Whereas the scientific and technical development of AGS is firmly in the hands of its founding scientists, general administration and management is provided by CambriaTech Genomics (CTG), a co-founding partner in AGS. Launched in 2001, CambriaTech Genomics (CTG) is CambriaTech's flagship programme in the biotechnology sector - an ambitious company comprising a number of technology development opportunities, ranging from small molecule discovery to mitochondrial therapeutics. CTG has a highly accomplished Scientific Advisory Board (SAB) chaired by Professor Joshua Lederberg which is fully involved in the scientific and strategic direction of AGS.